Spirulina Good for Diabetes, Cholesterol

June 9, 2010

1 Min Read
SupplySide Supplement Journal logo in a gray background | SupplySide Supplement Journal

MEXICO CITY, MexicoSpirulina maxima may be considered an alternative treatment for patients with non-alcoholic fatty liver diseases and dyslipidemic disorder, according to Mexican Researchers (J Med Case Reports. 2010;4:103). Non-alcoholic fatty liver diseases range from simple steatosis to non-alcoholic steatohepatitis. Spirulina maxima has been experimentally proven to possess in vivo and in vitro hepato-protective properties by maintaining the liver lipid profile. Three Hispanic Mexican patients (a 43-year-old man, a 77-year-old man and a 44-year-old woman) underwent ultrasonography and were treated with 4.5 g/d of Spirulina maxima for three months. Their blood samples before and after the treatment determined triglycerides, total cholesterol, high-density lipoprotein (HDL) cholesterol, alanine aminotransferase and low-density lipoprotein (LDL) cholesterol levels. Spirulina treatment had therapeutic effects as evidenced by ultrasonography and the aminotransferase data. Hypolipidemic effects were also shown.

 

 

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like